Pacebiotech Pharma (India) Pvt. Ltd.’s biotechnology injections manufacturing services distinguish our company via its creativity, modern technology, and commitment to developing high-quality, life-saving medicines. Therefore, we have developed our production facilities in Nahan Road, Vill. Surajpur, Paonta Sahib, Distt. Sirmour (H.P.)-173001. Here we have invested significantly in research and development to create new biologics, biosimilars, and novel drug delivery methods. Our experienced team is fully skilled and knowledgeable in sophisticated fields such as gene therapy, monoclonal antibodies, and MRNA technology. They also always focus on personalized medicine, which tailors therapies to specific genetic profiles. Moreover, the infrastructure of our company is GMP-certified (good manufacturing practices), and also our cell culture technologies, fermentation, and purification systems are all examples that we use only advanced bioprocessing processes. In this, there is also a huge importance of our automation and an integration system that always ensures precision, scalability, and cost-effectiveness. Because of all these things, we are able today to have the top demanded and diverse injections portfolio on our list. We manufacture a variety of biotech drugs, including vaccines for COVID-19 and HPV. Along with this, we have a huge collection of biological treatments for cancer, autoimmune illnesses, and diabetes. Another important thing is that our biosimilars are very cost-effective alternatives to branded biologics.
In addition, our strong focus on quality assurance always allows us to use our stringent quality control techniques to ensure product efficacy and safety. This compliance with international regulatory requirements such as the US FDA, EMA, and WHO-GMP. Thus our medicines products are continuously monitored throughout the supply chain. Even with this, innovation in drug delivery systems is an important element of our services. We develop improved delivery strategies, including sustained-release formulations, and also our drug delivery methods are specifically targeted. This contains patient-friendly formats such as prefilled syringes and autoinjectors. Moreover, we are always known to be committed to ecologically responsible manufacturing processes, and we also use renewable resources and green technologies to reduce carbon footprints. Consequently, we can say that our company gives the best opportunity to our customers or healthcare businesses to grow their business with our export of biotech medications to developed and emerging markets. Therefore we have also collaborated with foreign research institutions and regulatory bodies as well.
